Rifogal
CAS: 6998-60-3
Ref. 3D-GAA99860
10mg | 1.174,00 € | ||
25mg | 1.531,00 € | ||
50mg | 2.296,00 € | ||
100mg | 3.189,00 € | ||
250mg | 5.738,00 € |
Información del producto
- (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- Nsc 133100
- Rifamicina
- Rifamicine SV
- Rifampin SV
- Rifamycin SV
- Rifamycin SV MMX
- Ver más sinónimos
- Rifamycine
- Rifocin
- Rifocine
- Rifomycin
- Rifomycin SV
- Riphogal
- [2S-(2R*,12Z,14E,16R*,17R*,18S*,19S*,20S*,21R*,22S*,23R*,24E)]-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione
Rifogal is a rifamycin that is used to treat bacterial infections. It is an antibiotic that binds to DNA-dependent RNA polymerase, preventing transcription and replication. Rifogal has been shown to be effective against infections caused by Gram-positive bacteria, including Mycoplasma hominis and Streptococcus pneumoniae. In addition, this drug has been shown to have anti-inflammatory properties as it inhibits the toll-like receptor TLR4 pathway and reduces acute toxicities such as bowel disease and insect resistance.
Propiedades químicas
Consulta técnica sobre: 3D-GAA99860 Rifogal
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.